Vaxcyte Inc（PCVX）价格预测

$62.610

+1.171 (+1.87%)收盘时

价格预测

1-Day Price Prediction

-1.56%

1-Week Prediction

+0.49%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

PCVX 相似图表分析预测

Alphio's PCVX stock price prediction model matches the current Vaxcyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.06 (-1.56%). The 1-week path is $62.33 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Vaxcyte Inc 股票吗？

Vaxcyte Inc (PCVX) is a good buy right now due to its recent positive Phase 3 trial results for the VAX-31 vaccine, which led to a significant 60% stock surge, and analysts projecting a price target as high as $163, well above the current price of $60.43. The stock has shown a year-to-date increase of 30.07%, reflecting strong market interest and potential profitability. However, the main risk is the negative earnings trend, with projected EPS of -1.84 for the next earnings report, indicating ongoing financial challenges.

PCVX 股价于 Thursday 收于 $62.61，此前上涨 +1.87%

Vaxcyte Inc (PCVX) last closed at $62.0299988, losing -0.93%. These facts feed the 1-day and 1-week PCVX price prediction above.

预测驱动因素

Vaxcyte Inc（PCVX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 PCVX 最接近的股票，按相似度排序。

MRNA

85.14%

+55.40%

PCVX 季节性分析

Historically the probability of a positive October return for PCVX is 66.18%. February offers the highest probability of a positive month at 86.21%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…